Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

102.65
Delayed Data
As of 4:15pm ET
 +0.93 / +0.91%
Today’s Change
94.55
Today|||52-Week Range
147.17
-1.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line428.9M941.0M1.1B1.0B
 
 
 
 
 
Depreciation138.2M121.0M119.0M115.0M
 
 
 
 
 
Total Other Cash Flow452.0M195.0M256.0M170.0M
 
 
 
 
 
Funds From Operations931.9M1.2B1.3B1.3B
 
 
 
 
 
Funds From/For Other Operating Expenses-411.0M324.0M-286.0M207.0M
 
 
 
 
 
Net Cash Flow - Operating Activities1.3B853.0M1.6B1.1B
 
 
 
 
 
 
InvestingIncrease In Investments-730.4M-1.9B-1.7B-3.5B
 
 
 
 
 
Decrease In Investments92.6M266.0M1.8B1.2B
 
 
 
 
 
Capital Expenditures-66.4M-62.0M-70.0M-44.0M
 
 
 
 
 
Other Investing - Uses0.00-----27.0M
 
 
Other Investing - Sources--4.0M-4.0M--
 
 
 
Net Cash Flow Investing-704.2M-1.7B45.0M-2.4B
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.00--------
Long Term Debt Reduction0.00--------
Net Proceeds Stock Sale168.3M184.0M203.0M250.0M
 
 
 
 
 
Common Preferred Redeemed-133.6M-293.0M-518.0M-114.0M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing59.0M0.000.000.00
 
 
Other Uses - Financing41.1M0.000.000.00
 
 
Net Cash Flow - Financing52.6M-109.0M-315.0M132.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-44.0M19.0M41.0M5.0M
 
 
 
 
 
 
Net Change In Cash691.3M-916.0M1.3B-1.2B